Predictors for Chemotherapy Tolerance and Toxicity in Elderly Cancer Patients

Completed

• Conditions: 10027655; chemotherapy tolerance; toxicity

• Registration Number: NL-OMON39958
• Lead Sponsor: Sint Antonius Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 120

Inclusion Criteria

- Patients with a metastasized malignancy that will be treated with palliative chemotherapy.
- Patients with a non hogdkin lymphoma or a multiple myeloma that will be treated with chemotherapy
- Patients that are at least 70 years old at start of chemotherapy.
- Informed consent.

Exclusion Criteria

- Patients who have unadequate command of the Dutch language.
- Patients who are cognitive impaired.
- Patients with CNS metastases.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome is chemotherapy tolerance, defined as the ability to complete<br /><br>the first three cycles. This will then be correlated to the scores from the<br /><br>questionnaires. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome is (CTCAE graded) toxicity. This will then be correlated to<br /><br>the scores from the questionnaires.</p><br>